Abstract | OBJECTIVE: METHODS: (123)I-MIBG was intravenously injected in 23 idiopathic RBD patients with AHI < 5/h, 9 idiopathic RBD patients with 5 <or= AHI < 15/h, 15 idiopathic RBD patients complicated with moderate to severe OSA with AHI >or= 15/h, and 16 moderate to severe obstructive sleep apnea syndrome (OSAS) patients without RBD by polysomnography. RESULTS: Cardiac MIBG uptake based on H/M was significantly decreased in RBD patients with or without OSA compared with patients with moderate to severe OSAS without RBD. ROC analysis revealed that a delayed H/M cut-off value of 1.97 was useful for differentiating idiopathic RBD complicated by moderate to severe OSA from moderate to severe OSAS without RBD. CONCLUSIONS: (123)I-MIBG cardiac scintigraphy has the potential to distinguish true RBD from pseudo-RBD associated with OSA. These results are noteworthy because treatment options and follow-up protocols are determined based on evaluation of moderate to severe OSA complicated with RBD, such as overlapping primary sleep disorders.
|
Authors | Tomoyuki Miyamoto, Masayuki Miyamoto, Keisuke Suzuki, Akiko Ikematsu, Yasuhiro Usui, Yuichi Inoue, Koichi Hirata |
Journal | Sleep medicine
(Sleep Med)
Vol. 10
Issue 5
Pg. 577-80
(May 2009)
ISSN: 1389-9457 [Print] Netherlands |
PMID | 18752998
(Publication Type: Controlled Clinical Trial, Journal Article)
|
Chemical References |
- Iodine Radioisotopes
- Radiopharmaceuticals
- 3-Iodobenzylguanidine
|
Topics |
- 3-Iodobenzylguanidine
- Aged
- Cross-Sectional Studies
- Female
- Heart
(diagnostic imaging)
- Humans
- Iodine Radioisotopes
- Male
- Middle Aged
- Polysomnography
- Predictive Value of Tests
- REM Sleep Behavior Disorder
(diagnosis, etiology)
- Radionuclide Imaging
- Radiopharmaceuticals
- Respiratory Function Tests
- Severity of Illness Index
- Sleep Apnea, Obstructive
(diagnostic imaging, physiopathology, psychology)
|